(Q33908860)

29 July 2017

1 reference

title

Fully intermittent dosing with drugs for tuberculosis (English)

1 reference

29 July 2017

1 reference

H C Mwandumba

1

1 reference

29 July 2017

S B Squire

series ordinal

2

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 January 2000

1 reference

Cochrane Database of Systematic Reviews

29 July 2017

2000

0 references

published in

1 reference

29 July 2017

CD000970

1 reference

29 July 2017

2

1 reference

Five-year follow-up of a controlled trial of five 6-month regimens of chemotherapy for pulmonary tuberculosis. Hong Kong Chest Service/British Medical Research Council

29 July 2017

4

0 references

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000970

A 62-dose, 6-month therapy for pulmonary and extrapulmonary tuberculosis. A twice-weekly, directly observed, and cost-effective regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000970

Inhibition by pyrazinamide of tubercle bacilli within cultured human macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000970

Controlled trial of 2, 4, and 6 months of pyrazinamide in 6-month, three-times-weekly regimens for smear-positive pulmonary tuberculosis, including an assessment of a combined preparation of isoniazid, rifampin, and pyrazinamide. Results at 30 month

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000970

A controlled clinical comparison of 6 and 8 months of antituberculosis chemotherapy in the treatment of patients with silicotuberculosis in Hong Kong. Hong Kong Chest Service/tuberculosis Research Centre, Madras/British Medical Research Council

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000970

Community-based short-course treatment of pulmonary tuberculosis in a developing nation. Initial report of an eight-month, largely intermittent regimen in a population with a high prevalence of drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000970

10.1002/14651858.CD000970

21 January 2018

Identifiers

DOI

1 reference

29 July 2017

0 references

1 reference